SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-17-008669
Filing Date
2017-09-21
Accepted
2017-09-21 16:52:16
Documents
2
Period of Report
2017-09-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1439
2 POWER OF ATTORNEY poa-schelling.htm EX-24 5726
  Complete submission text file 0001654954-17-008669.txt   8851
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACER THERAPEUTICS INC. 222 THIRD STREET CAMBRIDGE MA 02142
Business Address
Schelling Chris (Reporting) CIK: 0001717241 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33004 | Film No.: 171096188